GENE ONLINE|News &
Opinion
Blog

Cancer
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Priority Review of Seagen’s Colorectal Cancer Treatment Wins FDA Acceptance
2022-09-19
Is Frozen-Thawed Embryo Transfer Associated with Increased Cancer Risk?
2022-09-16
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Kyowa Kirin’s Treatment for a Rare Cancer Disorder Approved by European Commission
2022-08-19
Bayer, Orion’s Prostate Cancer Drug Gets Approval For Second Indication
2022-08-10
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
1 2 3 21
LATEST
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!